BACKGROUND: Iso-osmolar contrast medium iodixanol has been reported to be less
nephrotoxic than selected low-osmolar contrast media (LOCM) in chronic kidney disease …

BACKGROUND: The choice of radiographic contrast media for use in patients at increased
risk of contrast-induced nephropathy (CIN) is of ongoing interest. METHODS: The current …

Objectives: This study sought to compare the nephrotoxicity of iodixanol and ioxaglate in
patients with renal impairment undergoing coronary angiography. Background: Iodixanol, a …

Objectives: We sought to compare the nephrotoxicity of isosmolar contrast medium (IOCM)
iodixanol with low-osmolar contrast media (LOCM) and to identify predictors of contrast …

This prospective, randomized, double-blind study was performed to compare the incidence
of contrast-induced nephropathy (CIN) after the administration of the iso-osmolar contrast …

Objectives: This study was undertaken to compare the renal safety as well as cardiovascular
(CV) effects and diagnostic image quality of iso‐osmolar iodixanol vs. low‐osmolar …

BACKGROUND: Acute renal failure after contrast-induced nephropathy is a clinically
important and costly complication after the use of iodine-based contrast media. We …

In patients with well-preserved renal function, the choice of contrast agent appears to have
little impact on the development of contrast-induced nephropathy (CIN). However, in patients …

Background—No direct comparisons exist of the renal tolerability of the low-osmolality
contrast medium iopamidol with that of the iso-osmolality contrast medium iodixanol in high …

INTRODUCTION AND OBJECTIVES: This study was designed to compare differences in the
incidence of contrast-induced nephropathy (CIN) and changes in serum creatinine (SCr) …